MUTATION_ID,VIRUS,GENOTYPE,GENE,AA,GCV,CDV,FOS,BCV,Letermovir,Tomeglovir,GW275175,Maribavir,Cyclopropavir,REF,REF+,TM,TM_RANK,co-gene,co-AA,PROTEIN_LOC,CREATED_DATE,CREATED_BY,NOTE
237,HCMV,MERLIN,UL27,A269T,,,,,,,,2,,Antiviral Research 163 (2019) 91–136,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
190,HCMV,MERLIN,UL56,A365S,,,,,2,,,,,Antiviral Research 163 (2019) 91–129,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
244,HCMV,MERLIN,UL27,A406V,,,,,,,,3.5,,Antiviral Research 163 (2019) 91–136,,in-vitro plaque removal assay,strong,UL27,C415*,,17/11/2019,OJCharles,
34,HCMV,MERLIN,UL97,A591V,1.3,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
38,HCMV,MERLIN,UL97,A594E,3,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
39,HCMV,MERLIN,UL97,A594G,13.5,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
40,HCMV,MERLIN,UL97,A594P,2.9,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
41,HCMV,MERLIN,UL97,A594T,2.7,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
42,HCMV,MERLIN,UL97,A594V,R,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,computer aided,hypothesised-unstrong,,,,17/11/2019,OJCharles,
42,HCMV,MERLIN,UL97,A594V,R,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,patient data,anecdotal,,,,17/11/2019,OJCharles,
42,HCMV,MERLIN,UL97,A594V,8.3,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro ish,anecdotal,,,,17/11/2019,OJCharles,
360,HCMV,MERLIN,UL97,A594V,8.6,,,,,,,,4.5,https://dx.doi.org/10.1128%2FAAC.01259-10,,in-vitro plaque removal assay,strong,,,,22/11/2019,OJCharles,
235,HCMV,MERLIN,UL27,C218del,,,,,,,,2.5,,Antiviral Research 163 (2019) 91–136,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
166,HCMV,MERLIN,UL56,C25F,,,,,5.4,,,,,Antiviral Research 163 (2019) 91–105,Chou et al. (2018b),in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
195,HCMV,MERLIN,UL56,C25F,,,,,46,,,,,Antiviral Research 163 (2019) 91–134,,clinical data,anecdotal,UL56,V231L,,17/11/2019,OJCharles,
184,HCMV,MERLIN,UL56,C325F,,,,,3000,,,,,Antiviral Research 163 (2019) 91–123,(Chou  2015),in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
185,HCMV,MERLIN,UL56,C325R,,,,,3000,,,,,Antiviral Research 163 (2019) 91–124,(Chou  2015),in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
187,HCMV,MERLIN,UL56,C325W,,,,,9000,,,,,Antiviral Research 163 (2019) 91–126,(Chou  2018b),in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
186,HCMV,MERLIN,UL56,C325Y,,,,,5500,,,,,Antiviral Research 163 (2019) 91–125,(Chou  2015),in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
27,HCMV,MERLIN,UL97,C480R,9,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro ish,anecdotal,,,,17/11/2019,OJCharles,
227,HCMV,MERLIN,UL97,C480R,,,,,,,,243,,Antiviral Research 163 (2019) 91–136,,clinical data,anecdotal,,,,17/11/2019,OJCharles,
28,HCMV,MERLIN,UL97,C518Y,12,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
36,HCMV,MERLIN,UL97,C592F,31.5,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro plaque removal assay,strong,,,,17/11/2019,OJCharles,
37,HCMV,MERLIN,UL97,C592G,2.9,,,,,,,,,Rev. Med. Virol. 2016; 26: 161–182,,in-vitro ish,anecdotal,,,,17/11/2019,OJCharles,
359,HCMV,MERLIN,UL97,C592G,3,,,,,,,,3.3,https://dx.doi.org/10.1128%2FAAC.01259-10,,computer aided,hypothesised-unstrong,,,,22/11/2019,OJCharles,
